Jun 10, 2019
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
May 14, 2019
Evofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
May 07, 2019
Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update
Apr 23, 2019
Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora
Apr 11, 2019
PDL BioPharma Announces Equity Investment in Evofem Biosciences
Apr 11, 2019
Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma
Apr 03, 2019
Evofem Biosciences to Present at Needham Healthcare Conference
Mar 01, 2019
Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Feb 19, 2019
Evofem Biosciences to Report Fourth Quarter and Year-end 2018 Results and Provide Corporate Update on March 1, 2019
Jan 03, 2019
Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
Dec 17, 2018
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control
Nov 08, 2018
Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy
Nov 07, 2018
Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 01, 2018
Evofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On Demand and Woman Controlled
Oct 24, 2018
Evofem Biosciences to Report Third Quarter 2018 Results on November 7, 2018
Oct 09, 2018
Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Lead Product Candidate, Amphora, and its Role as a Multipurpose Vaginal pH Regulator Presented at 2018 American Society of Reproductive Medicine Annual Congress
Oct 03, 2018
Evofem Biosciences to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora at the 2018 International Federation of Gynecology and Obstetrics (FIGO) World Congress
Sep 21, 2018
New Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Amphora and its Role as a Multipurpose Vaginal pH Regulator (MVP-R) to be Presented at the 2018 American Society For Reproductive Medicine (ASRM) Annual Congress
Aug 23, 2018
Evofem Biosciences to Present at 20th Annual Global Investment Conference on September 6, 2018
Aug 02, 2018
Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update